Journal of Shanghai Jiao Tong University (Medical Science) >

2023 , Vol. 43 >Issue 1: 1 - 7

DOI: https://doi.org/10.3969/j.issn.1674-8115.2023.01.001

Basic research

Role of methyltransferase like 3 regulating pri-miR-21 methylation in renal fibrosis of diabetes nephropathy

  • Jiajin WU ,
  • Chen ZHONG ,
  • Dawei LI ,
  • Ruoyang CHEN ,
  • Junwen QU ,
  • Ming ZHANG
Expand
  • Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
ZHANG Ming, E-mail: drmingzhang@126.com.

Received date: 2022-06-01

  Accepted date: 2022-12-30

  Online published: 2023-01-28

Supported by

National Natural Science Foundation of China(81900680)

Fold

Abstract

Objective ·To investigate the role of methyltransferase like 3 (METTL3) acting on N6-methyladenosine (m6A) and regulating pri-miR-21 methylation in the renal fibrosis of diabetic nephropathy (DN). Methods ·Eight-week-old male db/db mice were used as DN models, and db/m mice were used as controls. The mice were randomly divided into 4 groups according to whether they received the treatment of 3-deazaadenosine (DAA) by tail vein injection or not (5 mice/group): db/m group, db/db group, db/m+DAA group and db/db+DAA group. From the age of 8 weeks, DAA was injected once per 5 d for a total of 8 times. After the DAA intervention, the mice were kept until they were 19 weeks old. The blood, the urine and the kidney tissue samples of the mice were collected, and blood glucose (BG), serum creatinine (Scr), and urinary albumin-to-creatinine ratio (ACR) were detected. The kidneys were stained with hematoxylin-eosin (H-E), Masson and sirius red to observe the pathological changes. The methylation level of m6A in total RNAs of the kidney was detected with the kit. The expression levels of METTL3 and fibrosis-related proteins in the kidney were detected by Western blotting. The overall pri-miR-21 and the mature miR-21 were detected by real-time quantitative PCR. After enrichment of the m6A-methylated RNAs in the kidney by immunomagnetic beads, the methylated pri-miR-21 at m6A was detected by PCR. Results ·Compared with the db/m group, the levels of BG, Scr, and ACR, and METTL3, m6A methylation level, fibrosis-related proteins, overall pri-miR-21, m6A-methylated pri-miR-21 and mature miR-21 in the kidney in the db/db group significantly increased (P<0.05). Furthermore, the mesangial matrix in the kidney increased, glomerular basement membrane thickened, and the accumulation of collagen fibers increased significantly in the db/db group. Compared with the db/db group, the levels of BG, Scr, and ACR, and m6A methylation level, fibrosis-related proteins, m6A-methylated pri-miR-21 and mature miR-21 in the kidney in the db/db+DAA group decreased significantly (P<0.05) and the degree of renal injury and fibrosis was significantly reduced, but the expression level of overall pri-miR-21 significantly increased (P=0.000). The expression level of METTL3 protein did not change significantly. Conclusion ·The m6A methylation modification of pri-miR-21 promotes the maturation of miR-21, thereby promoting the occurrence and development of renal fibrosis in DN mice; inhibition of METTL3 can inhibit renal fibrosis in DN mice by regulating m6A methylation of pri-miR-21.

Key words： diabetic nephropathy (DN); renal fibrosis; N6-methyladenosine (m6A); methyltransferase like 3 (METTL3); pri-miR-21; miR-21

Cite this article

Jiajin WU , Chen ZHONG , Dawei LI , Ruoyang CHEN , Junwen QU , Ming ZHANG . Role of methyltransferase like 3 regulating pri-miR-21 methylation in renal fibrosis of diabetes nephropathy[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023 , 43(1) : 1 -7 . DOI: 10.3969/j.issn.1674-8115.2023.01.001

References

1 CHANG Y E, MORADI H, KALANTAR-ZADEH K. Emerging paradigms of treating diabetic nephropathy[J]. Lancet Diabetes Endocrinol, 2018, 6(12): 912-913.
2 CHERNEY D Z I, ODUTAYO A, VERMA S. A big win for diabetic kidney disease: CREDENCE[J]. Cell Metab, 2019, 29(5): 1024-1027.
3 DE BOER I H. A new chapter for diabetic kidney disease[J]. N Engl J Med, 2017, 377(9): 885-887.
4 JARDINE M J, MAHAFFEY K W, PERKOVIC V. Canagliflozin and renal outcomes in diabetic nephropathy. Reply[J]. N Engl J Med, 2019, 381(11): 1089-1090.
5 CHAU B N, XIN C Y, HARTNER J, et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways[J]. Sci Transl Med, 2012, 4(121): 121ra18.
6 WANG J Y, GAO Y B, ZHANG N, et al. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy[J]. Am J Physiol Renal Physiol, 2014, 306(5): F486-F495.
7 DEY N, DAS F, MARIAPPAN M M, et al. MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes[J]. J Biol Chem, 2011, 286(29): 25586-25603.
8 YANG C, HU Y Y, ZHOU B, et al. The role of m6A modification in physiology and disease[J]. Cell Death Dis, 2020, 11(11): 960.
9 MATHIYALAGAN P, ADAMIAK M, MAYOURIAN J, et al. FTO-dependent N6-methyladenosine regulates cardiac function during remodeling and repair[J]. Circulation, 2019, 139(4): 518-532.
10 LIU E P, LV L, ZHAN Y H, et al. METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-κB pathway activation[J]. J Cell Mol Med, 2021, 25(16): 7660-7674.
11 CHEN J, ZHANG M J, ZHANG X, et al. EZH2 inhibitor DZNep modulates microglial activation and protects against ischaemic brain injury after experimental stroke[J]. Eur J Pharmacol, 2019, 857: 172452.
12 OVECHKIN A V, TYAGI N, SEN U, et al. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice[J]. Am J Physiol Lung Cell Mol Physiol, 2006, 291(5): L905-L911.
13 MEYER K D, SALETORE Y, ZUMBO P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons[J]. Cell, 2012, 149(7): 1635-1646.
14 NIU Y M, ZHAO X, WU Y S, et al. N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function[J]. Genom Proteom Bioinform, 2013, 11(1): 8-17.
15 LIU J Z, YUE Y N, HAN D L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation[J]. Nat Chem Biol, 2014, 10(2): 93-95.
16 MAGHBOOLI Z, LARIJANI B, EMAMGHOLIPOUR S, et al. Aberrant DNA methylation patterns in diabetic nephropathy[J]. J Diabetes Metab Disord, 2014, 13(1): 69.
17 MARUMO T, YAGI S, KAWARAZAKI W, et al. Diabetes induces aberrant DNA methylation in the proximal tubules of the kidney[J]. J Am Soc Nephrol, 2015, 26(10): 2388-2397.
18 JIANG L, LIU X Q, HU X R, et al. METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy[J]. Mol Ther, 2022, 30(4): 1721-1740.
19 LI Q H, ZHU L Q, YAN Y M, et al. S-adenosyl homocysteine hydrolase (SAHH) accelerates flagellar regeneration in Dunaliella salina[J]. Curr Microbiol, 2013, 67(2): 249-254.
20 ZACCARA S, RIES R J, JAFFREY S R. Reading, writing and erasing mRNA methylation[J]. Nat Rev Mol Cell Biol, 2019, 20(10): 608-624.
21 DE JESUS D F, ZHANG Z J, KAHRAMAN S, et al. m6A mRNA methylation regulates human β-cell biology in physiological states and in type 2 diabetes[J]. Nat Metab, 2019, 1(8): 765-774.
22 XIE W, MA L L, XU Y Q, et al. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism[J]. Biochem Biophys Res Commun, 2019, 518(1): 120-126.
23 张丹亭. S-腺苷高半胱氨酸水解酶抑制剂在肝脏葡萄糖糖代谢中的作用[D]. 长春: 东北师范大学, 2019.
23 ZHANG D T. 3-Deazaadenosine, mechanism of action in liver glucose metabolism[D]. Changchun: Northeast Normal University, 2019.
24 ZHONG X, CHUNG A C K, CHEN H Y, et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes[J]. Diabetologia, 2013, 56(3): 663-674.
25 WANG J Y, GAO Y B, ZHANG N, et al. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy[J]. Mol Cell Endocrinol, 2014, 392(1-2): 163-172.
26 SEKAR D, VENUGOPAL B, SEKAR P, et al. Role of microRNA 21 in diabetes and associated/related diseases[J]. Gene, 2016, 582(1): 14-18.
27 DIAO L T, XIE S J, LEI H, et al. METTL3 regulates skeletal muscle specific miRNAs at both transcriptional and post-transcriptional levels[J]. Biochem Biophys Res Commun, 2021, 552: 52-58.
28 MICHLEWSKI G, CáCERES J F. Post-transcriptional control of miRNA biogenesis[J]. RNA, 2019, 25(1): 1-16.
Options
Outlines

/

〈 〉